Neurology
1 drug is in development for Gaucher Disease.
- Companies
- 1
- Clinical trials
- 10
Prepared research question
Which programs lead the Gaucher Disease pipeline—and what evidence could change the picture?
Traceable citations · Unknowns marked
Drug Pipeline by Phase
| Drug | Company |
|---|---|
| elelyso | Protalix BioTherapeutics, Inc. (PLX) |
About this indication
Gaucher Disease context
Also known as: Acid beta-Glucosidase Deficiency, Acid beta-Glucosidase Deficiency Disease, Cerebroside Lipidoses, Glucosyl, Cerebroside Lipidosis Syndromes, Cerebroside Lipidosis, Glucosyl, Deficiencies, Glucocerebrosidase, Deficiency Disease, Glucocerebrosidase, Deficiency Diseases, Glucocerebrosidase, Deficiency, Glucocerebrosidase, Disease, Gaucher's, Diseases, Gauchers, Glucocerebrosidoses, Glucocerebrosidosis, Glucosylceramidase Deficiency, Glucosylceramide Beta-Glucosidase Deficiency, Glucosylceramide Beta-Glucosidase Deficiency Disease, Glucosylceramide Lipidoses, Histiocytoses, Kerasin, Histiocytoses, Lipoid (Kerasin Type), Histiocytosis, Kerasin, Histiocytosis, Lipoid (Kerasin Type), Kerasin Lipoidoses, Kerasin thesaurismoses, Lipidosis Syndrome, Cerebroside, Lipidosis, Glucosylceramide, Lipoidosis, Kerasin, Splenomegaly, Gaucher, Syndrome, Gaucher, thesaurismosis, Kerasin
Frequently asked questions
How many drugs are in development for Gaucher Disease?
BioSniper tracks 1 drug in development for Gaucher Disease across 1 company.
How many clinical trials target Gaucher Disease?
There are 10 clinical trials targeting Gaucher Disease tracked by BioSniper.